BLTE
Price
$56.40
Change
-$0.88 (-1.54%)
Updated
Apr 17 closing price
Capitalization
1.82B
19 days until earnings call
LENZ
Price
$23.82
Change
+$0.76 (+3.30%)
Updated
Apr 17 closing price
Capitalization
656.08M
Ad is loading...

BLTE vs LENZ

Header iconBLTE vs LENZ Comparison
Open Charts BLTE vs LENZBanner chart's image
Belite Bio
Price$56.40
Change-$0.88 (-1.54%)
Volume$20.44K
Capitalization1.82B
LENZ Therapeutics
Price$23.82
Change+$0.76 (+3.30%)
Volume$218.76K
Capitalization656.08M
BLTE vs LENZ Comparison Chart
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. LENZ commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Hold and LENZ is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (BLTE: $56.40 vs. LENZ: $23.82)
Brand notoriety: BLTE and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 46% vs. LENZ: 94%
Market capitalization -- BLTE: $1.82B vs. LENZ: $656.08M
BLTE [@Biotechnology] is valued at $1.82B. LENZ’s [@Biotechnology] market capitalization is $656.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 4 TA indicator(s) are bullish while LENZ’s TA Score has 7 bullish TA indicator(s).

  • BLTE’s TA Score: 4 bullish, 6 bearish.
  • LENZ’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а -3.62% price change this week, while LENZ (@Biotechnology) price change was +28.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 06, 2025.

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.82B) has a higher market cap than LENZ($656M). BLTE YTD gains are higher at: -10.618 vs. LENZ (-17.492).
BLTELENZBLTE / LENZ
Capitalization1.82B656M278%
EBITDA-35.42MN/A-
Gain YTD-10.618-17.49261%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/A217M-
Total DebtN/A1.58M-
TECHNICAL ANALYSIS
Technical Analysis
BLTELENZ
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MALRX19.64N/A
N/A
BlackRock Advantage Large Cap Core Instl
TCAGX7.23N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl C
SBACX26.29N/A
N/A
Touchstone Balanced C
MCECX11.77N/A
N/A
Martin Currie Emerging Markets C
TCIWX23.35N/A
N/A
Nuveen International Eq Idx W

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-1.54%
RAIN - BLTE
48%
Loosely correlated
-5.92%
ACOG - BLTE
24%
Poorly correlated
-3.06%
ALEC - BLTE
24%
Poorly correlated
-5.95%
TVTX - BLTE
23%
Poorly correlated
+2.40%
LENZ - BLTE
22%
Poorly correlated
+3.30%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+3.30%
KYMR - LENZ
46%
Loosely correlated
+3.80%
ELVN - LENZ
44%
Loosely correlated
+2.86%
ACLX - LENZ
43%
Loosely correlated
+2.19%
ETNB - LENZ
42%
Loosely correlated
+2.89%
ERAS - LENZ
42%
Loosely correlated
-0.85%
More